from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1516c/-

LFCtreatmentdescriptionclass of inhibitor

-0.257

Amikacinug/mL Amikacintranslation

0.598

Cap5-10ug/mL Capreomycintranslation

1.130

Rox10-50 ug/mL Roxithromycintranslation

-0.182

SM2-5 ug/mL Streptomycintranslation

-0.241

Tet5-10 ug/mL Tetracyclinetranslation

0.682

Rif0.2-5ug/mL Rifampicintranscription

0.655

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.021

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.893

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.756

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.573

Clofazimine10-13 ug/mL Clofaziminerespiration

0.162

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.544

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.874

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.823

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.143

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.320

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.121

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.876

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.753

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.608

KCN5-20 ug/mL Potassium cyaniderespiration

-1.644

NaN30.2-2 mM Sodium aziderespiration

0.929

Nigericin50 uM Nigericinrespiration

-0.660

TRC10-150 ug/mL Triclosanrespiration

-0.637

TRZ10-25 ug/mL Thioridazinerespiration

-0.672

Valinomycin0.5-10 uM Valinomycinrespiration

2.680

ZnSO42 mM ZnSO4respiration

-0.810

menadione6-10 ug/mL Menadionerespiration

-0.265

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.153

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.737

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.034

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.908

NRP_1Non-replicating persistence stage 1dosRassociated

0.544

Amp0.2mg/mL AmpicillincellWall

-0.136

Cephalexin20-100 ug/mL CephalexincellWall

0.238

Cerulenin0.32-5 ug/mL CerulenincellWall

0.151

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.215

EMB10-20 ug/mL EthambutolcellWall

-0.834

Eta12-40 ug/mL EthionamidecellWall

-0.941

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.080

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.311

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.492

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.880

BZA0.12 mg/mL BenzamidearomaticAmides

0.726

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.472

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

1.016

H2O24 mM hydrogen peroxideDNAdamaging

0.346

Levo10 ug/mL LevofloxacinDNAdamaging

1.289

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.564

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.169

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.794

UVUV-irradiationDNAdamaging

-0.708

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.664

Antimycin12.5-50 ug/mL Antimycin A?

0.162

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

1.021

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.497

PA_2110-50 ug/mL Antitubercular compound PA-21?

-2.341

PA8240.2-2 ug/mL PA-824?

-1.712

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.677

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.074

Verapamil50 uM Verapamil?

-0.051

mercaptoethanol2 mM 2-Mercaptoethanol?

0.195

methoxatin10-20 ug/mL Methoxatin?